SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950136-08-001313
Filing Date
2008-03-13
Accepted
2008-03-13 17:09:52
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K file1.htm 10-K 4104116
2 LIST OF SUBSIDIARIES file2.htm EX-21 1885
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCT FIRM file3.htm EX-23.1 2869
4 CERTIFICATION PURSUANT TO SECTION 302 file4.htm EX-31.1 16533
5 CERTIFICATION PUSUANT TO SECTION 302 file5.htm EX-31.2 16735
6 CERTIFICATION PURSUANT TO SECTION 906 file6.htm EX-32.1 5563
7 CERTIFICATION PURSUANT TO SECTION 906 file7.htm EX-32.2 5840
8 ebox.gif GRAPHIC 58
9 xbox.gif GRAPHIC 63
10 spacer.gif GRAPHIC 43
11 html_301611graph.jpg GRAPHIC 28588
  Complete submission text file 0000950136-08-001313.txt   4195281
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50626 | Film No.: 08686824
SIC: 2834 Pharmaceutical Preparations